Transcripts Northwest Biotherapeutics, Inc. Börse Stuttgart

Stocks

Delayed Börse Stuttgart Other stock markets 11:03:45 15/07/2026 +03			5-day change	1st Jan Change
0.1500 ^EUR	0.00%		-6.25%	-27.18%

07-08	Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of Dcvax-L for Glioblastoma	CI
05-15	Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

29/06/24	Northwest Biotherapeutics, Inc. - Shareholder/Analyst Call
30/12/22	Northwest Biotherapeutics, Inc. - Shareholder/Analyst Call
18/04/20	Northwest Biotherapeutics, Inc. - Shareholder/Analyst Call